Clinical Trials Browser

Stomach Neoplasms × pyrotinib × Clear all

NCT05111444 2021-11-08

Camrelizumab Plus Pyrotinib Plus Chemotherapy in Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Advanced Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma

Phase 2 Unknown

Gastrointestinal

Stomach Neoplasms

NCT02500199 2021-02-01

Phase I Study of Pyrotinib in Patients With HER2-positive Solid Tumors

Phase 1 Unknown

BreastGastrointestinal

Breast Neoplasms, Stomach Neoplasms